ici 164384 has been researched along with mifepristone in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 13 (86.67) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wakeling, AE | 1 |
McDonnell, DP; O'Malley, BW; Vegeto, E | 1 |
Benhamou, B; Berry, M; Bocquel, MT; Garcia, T; Gofflo, D; Gronemeyer, H; Lerouge, T; Metzger, D; Meyer, ME; Tora, L | 1 |
Chambon, P; Green, S; Jin, JR; Webster, NJ | 1 |
Coutts, A; Murphy, LC; Murphy, LJ | 1 |
Adessi, GL; Beck, L; Cardis, P; Mularoni, A; Nicollier, M | 1 |
Crombie, DL; Hayes, JS; McDonnell, DP; Mukherjee, R; Wang, MW | 1 |
Goldman, ME; McDonnell, DP | 1 |
Musgrove, EA; Sutherland, RL | 1 |
Manning, DL; Nicholson, RI | 1 |
Catherino, WH; Jeng, MH; Jordan, VC | 1 |
Hamilton, JA; Lee, CS; Musgrove, EA; Sutherland, RL; Sweeney, KJ; Watts, CK | 1 |
Aguado, LI; Carrizo, DG; Deis, RP; Rastrilla, AM; Stati, AO; Stocco, CO; TellerĂa, CM | 1 |
Gurpide, E; Markiewicz, L | 1 |
Dong, YL; Yallampalli, C | 1 |
2 review(s) available for ici 164384 and mifepristone
Article | Year |
---|---|
Steroid antagonists as nuclear receptor blockers.
Topics: Androgen Antagonists; Anilides; Animals; Estradiol; Estrogen Antagonists; Estrogens; Humans; Mifepristone; Nitriles; Polyunsaturated Alkamides; Rats; Receptors, Estrogen; Tamoxifen; Tosyl Compounds | 1992 |
Mechanisms of antihormone action.
Topics: Animals; DNA-Binding Proteins; Estradiol; Estrogen Antagonists; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Receptors, Estrogen; Receptors, Progesterone; Receptors, Steroid | 1992 |
13 other study(ies) available for ici 164384 and mifepristone
Article | Year |
---|---|
Identification of a negative regulatory function for steroid receptors.
Topics: beta-Galactosidase; Estradiol; Estrogen Antagonists; Ethyl Methanesulfonate; Genetic Complementation Test; Genetic Vectors; Homeostasis; Humans; Kinetics; Mifepristone; Mutagenesis; Nafoxidine; Plasmids; Polyunsaturated Alkamides; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Progesterone; Recombinant Proteins; Restriction Mapping; Saccharomyces cerevisiae; Transcription, Genetic | 1992 |
The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function.
Topics: DNA; Estradiol; Estrenes; Estrogen Antagonists; Estrogens; Glucocorticoids; HeLa Cells; Hormones; Humans; Mifepristone; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Glucocorticoid; Tamoxifen; Transcription Factors; Transcription, Genetic; Transfection | 1988 |
Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens.
Topics: Breast Neoplasms; Carrier Proteins; Culture Media, Conditioned; Dexamethasone; Estradiol; Estrogen Antagonists; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Protein 5; Medroxyprogesterone Acetate; Mifepristone; Neoplasm Proteins; Polyunsaturated Alkamides; Pregnenediones; Progesterone; Progestins; Tumor Cells, Cultured | 1994 |
Adenosine 3',5'-monophosphate mediates progesterone effect on sulfate uptake in endometrial epithelial cells.
Topics: Animals; Cells, Cultured; Cyclic AMP; Endometrium; Epithelium; Estradiol; Female; Guinea Pigs; Mifepristone; Polyunsaturated Alkamides; Progesterone; Sulfates | 1995 |
Creatine kinase activity as an indicator of unopposed estrogen action in the mouse uterus associated with anti-progesterone treatment.
Topics: Animals; Brain; Creatine Kinase; Decidua; Estradiol; Female; Gene Expression; HeLa Cells; Humans; Isoenzymes; Male; Mice; Mice, Inbred BALB C; Mifepristone; Polyunsaturated Alkamides; Progesterone; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Progesterone; Recombinant Fusion Proteins; Transfection; Uterus | 1994 |
RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism.
Topics: Animals; Base Sequence; Binding Sites; Binding, Competitive; Cell Line; Chlorocebus aethiops; DNA-Binding Proteins; Estradiol; Estrogen Antagonists; Gene Expression Regulation; Humans; Kidney; Mifepristone; Molecular Sequence Data; Oligodeoxyribonucleotides; Plasmids; Polyunsaturated Alkamides; Progesterone; Promoter Regions, Genetic; Receptors, Progesterone; Transfection | 1994 |
Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes.
Topics: Breast Neoplasms; Cell Cycle; Cyclin D1; Cyclins; Dose-Response Relationship, Drug; Estradiol; Humans; Mifepristone; Oncogene Proteins; Polyunsaturated Alkamides; Pregnenediones; Progesterone Congeners; Progestins; Proto-Oncogene Proteins c-myc; RNA, Messenger; S Phase; Tumor Cells, Cultured | 1993 |
Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestins.
Topics: Breast Neoplasms; DNA, Neoplasm; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Tumor Cells, Cultured | 1993 |
Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism.
Topics: Base Sequence; Breast Neoplasms; Cell Division; Estradiol; Estrogens; Female; Gene Expression; Humans; In Vitro Techniques; Mifepristone; Molecular Sequence Data; Norgestrel; Norpregnenes; Polyunsaturated Alkamides; Promoter Regions, Genetic; Receptors, Estrogen; Regulatory Sequences, Nucleic Acid; Transcription, Genetic; Tumor Cells, Cultured | 1993 |
Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
Topics: Breast Neoplasms; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Cyclins; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, myc; Growth Substances; Histones; Humans; Insulin; Kinetics; Mifepristone; Polyunsaturated Alkamides; Pregnenediones; Progesterone Congeners; Protein Kinases; Protein Serine-Threonine Kinases; Recombinant Proteins; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1993 |
Dual regulation of luteal progesterone production by androstenedione during spontaneous and RU486-induced luteolysis in pregnant rats.
Topics: 17-Hydroxysteroid Dehydrogenases; 20-alpha-Hydroxysteroid Dehydrogenase; 20-Hydroxysteroid Dehydrogenases; Adrenalectomy; Androstenedione; Animals; Aromatase Inhibitors; Cells, Cultured; Corpus Luteum; Dihydrotestosterone; Estradiol; Female; Hormone Antagonists; Luteolysis; Luteolytic Agents; Menstruation-Inducing Agents; Mifepristone; Organ Size; Polyunsaturated Alkamides; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Wistar; Testosterone | 1995 |
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured | 1997 |
Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP(2) and contractile FP receptors in the rat uterus.
Topics: Animals; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation; Hormone Antagonists; Labor, Obstetric; Mifepristone; Polyunsaturated Alkamides; Postpartum Period; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Steroids; Uterine Contraction; Uterus | 2000 |